TUE, SEP. 21
2nd Day

DNA, Human Health and Disease (9.00 am - 12.30 am) chaired by: Claudio Basilico, Department of Microbiology, NYU School of Medicine, New York, USA , Guido Coggi, Department of Pathology, University of Milan, Italy (UNABLE)
The Future of DNA Technology: Transforming the Material world.	William Haseltine, Haseltine Foundation for Medical Sciences and the Arts, USA
New insights into the mechanisms of human disease.	Veronica van Heyningen , Human Genetics Unit, Institute of Genetics and Molecular Medicine, Edinburgh, UK
Learning Biology from the study of Genetic Diseases.	Andrea Ballabio, Telethon Institute of Genetics and Medicine, Napoli, Italy
Gene Therapy for congenital and acquired disorders: promoting the progress of clinical applications.	Claudio Bordignon, University Vita Salute San Raffaele, Milan, Italy
Next Generation Microbial Genomics: The Human Microbiome Project.	George M. Weinstock, The Genome Center, Washington University, St. Louis, USA
Longevity Genomics.	Pier Giuseppe Pelicci, Experimental Oncology Department, European Institute of Oncology; University of Milan, Italy

Cancer genetics - AIRC Symposium (2.00 pm - 5.00 pm) chaired by: Maria Ines Colnaghi, Italian Association for Cancer Research , Pier Paolo Di Fiore, IFOM Foundation, The Firc Institute of Molecular Oncology; University of Milan, Italy
	Umberto Veronesi, European Institute of Oncology, Milan, Italy
Common genetic variants, risk, and applications in cancer.	Bruce Ponder, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, UK
Linkages Between Genome Disorder and Breast Cancer Development.	David Livingston, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Cancer Stem Cells: Getting to the Root of Cancer.	Dominique Bonnet, Cancer Research UK, London Research Institute, UK
The Era of Genome-based Targeted Therapy of Cancer.	Yosef Yarden , Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel

Programme overview